Novo Nordisk has questioned the FDA to block production of compounded copies of copyright, arguing that it’s way too challenging to do safely. It’s the latest escalation within a brewing war involving pharmaceutical providers and compounders.Ron Gershoni, co-founding father of vape producer Jetty Extracts, who sits within the board from the Cal